Literature DB >> 27015619

Incidence rate of anemia in inflammatory bowel diseases.

Özlen Atuğ1, Haluk Tarık Kani, Munkhtsetseg Banzragch, Neşe İmeryüz, Hakan Akın.   

Abstract

BACKGROUND/AIMS: To determine the incidence rate and distribution of anemia types over time from an Inflammatory Bowel Disease (IBD) patient cohort spanning 18 years.
MATERIALS AND METHODS: Between January 1995 and November 2013, the University Hospital digital databases as well as hard copies of patients' files were reviewed retrospectively. IBD patients with at least one complete blood count (CBC) report were included in this study.
RESULTS: We obtained 941 IBD patients' records; 375 (39.9%) patients were diagnosed with Crohn's disease (CD), and 566 (60.1%) patients had ulcerative colitis (UC). Anemia was detected in 548 (58.2%) patients. Female patients were more frequently anemic than male patients (68.4% vs. 49.7%, p=0.001). The frequency of anemia was slightly higher in patients with CD (62.1%) than in patients with UC (55.7%) (p=0.04). The incidence rate of anemia for the entire IBD patient cohort was calculated as 103.45 per 1,000 patient-years. The correlation between the age of the IBD disease and the presence of anemia exhibited a high correlation coefficient of Pearson's r=0.702.
CONCLUSION: This is the first study to report the incidence rate of anemia (103.45 per 1,000 patient-years) in a long-term cohort of IBD patients.

Entities:  

Mesh:

Year:  2016        PMID: 27015619     DOI: 10.5152/tjg.2016.16011

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  6 in total

Review 1.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

2.  Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.

Authors:  Emily A Minor; Justin T Kupec; Andrew J Nickerson; Karthikeyan Narayanan; Vazhaikkurichi M Rajendran
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

3.  Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease.

Authors:  Haluk Tarık Kanı; İlkay Ergenç; Hüseyin Arıkan; Zeynep Kömesli; Berfin Seyrek; Coşkun Özer Demirtaş; Yeşim Özen Alahdab; Neşe İmeryüz; Özlen Atuğ
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

4.  Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study.

Authors:  Carl Eriksson; Ida Henriksson; Ole Brus; Yaroslava Zhulina; Nils Nyhlin; Curt Tysk; Scott Montgomery; Jonas Halfvarson
Journal:  Aliment Pharmacol Ther       Date:  2018-08-01       Impact factor: 8.171

5.  The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease.

Authors:  Małgorzata Woźniak; Magdalena Barańska; Ewa Małecka-Panas; Renata Talar-Wojnarowska
Journal:  Prz Gastroenterol       Date:  2019-03-12

6.  Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.

Authors:  Göksel Bengi; Hatice Keyvan; Seda Bayrak Durmaz; Hale Akpınar
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.